Table 1 Basic characteristics of patients
From: Clinical outcomes of graves’ ophthalmopathy treated with intensity modulated radiation therapy
Variables | No. | Percent |
|---|---|---|
Gender | ||
Female | 64 | 55.2% |
Male | 52 | 44.8% |
Previous thyroid treatment | ||
Medication | 84 | 72.4% |
Thyroidectomy | 14 | 12.1% |
RAI | 43 | 37.1% |
None | 20 | 17.2 |
Smoking status | ||
Current smoker | 42 | 36.2% |
Former smoker | 11 | 9.5% |
Non-smoker | 63 | 54.3% |
Duration of GO prior to RT | ||
≤ 6 months | 41 | 35.3% |
6–18 months | 48 | 41.4% |
> 18 months | 27 | 23.3% |
Previous steroid use | ||
Yes | 39 | 33.6% |
No | 77 | 66.4% |
Response to previous steroids | ||
None | 10 | 25.6% |
Mild to moderate | 29 | 74.4% |
Significant | 0 | 0% |
Concurrent steroid use during RT | ||
Yes | 21 | 18.1% |
No | 95 | 81.9% |
Symptom severity scores at enrollment | ||
2 to 5 | 32 | 27.6% |
6 to 10 | 63 | 54.3% |
11 to 14 | 21 | 18.1% |